Antivirals Flashcards
(57 cards)
HSV1
Mouth/face Skin Esophagus Brain Lungs (pneumonia uncommon)
HSV2
Genitals Rectum Skin Hands Meninges
HSV3
Varicella Zoster (VSV)
Chicken pox
Shingles
Pneumonia
HSV4
Epstein-Barr (EBV)
Mononucleosis
HSV5
Cytomegalovirus (CMV)
Systemic hematopoietic disorders
Interstitial pneumonia
Acyclovir - Target
HSV2 - mainly
HSV3
Acyclovir - MOA
Guanosine Analog
Needs viral thymadine kinase
Acyclovir - Resistance
Altered/deficient thymadine kinase
Altered DNA polymerase
Acyclovir - PK
IV administered
Distributes to well (inc. CSF)
Renally cleared
Valcyclovir
Same as acyclyovir but PO prodrug
Acyclovir - ADR
Nephrotoxicity - can be avoided with hydration N/V/D Neurotoxicity - Siezure, tremor, CNS Hematologic toxicity - Thrombocytopenia Irritation if applied topically
Ganciclovir - Target
HSV5 Mainly
HSV2
HSV3
Used as prophylaxis in transplant patients
Ganciclovir - MOA
Guanosine Analog - same as acyclovir
Requires Viral thymadine kinase
Valganciclovir
Oral prodrug of Ganciclovir
Ganciclovir - PK
IV Administered
Renally cleared
Ganciclovir - ADR
Myelosuppression Thrombocytopenia Neurotoxicity N/V/D Phlebitis Fever Carcinogenic/Teratogenic
Penciclovir - Target
HSV1
HSV2
HSV3
Penciclovir - MOA
Does not terminate DNA chain
Guanosine analog
Requires Viral thymadine kinase
Penciclovir - PK
Topically administered
Long half life (7-20 hours)
Renally cleared
Penciclovir - ADR
N/V/D
CNS effects
Rash/Hives
May be carcinogenic
Penciclovir - Resistance
Deficient/mutated thymadine kinase
Famcyclovir
PO prodrug of Penciclovir
Cidofivir - Target
HSV5
In vitro activity against other HSVs
Experimental against adenovirus
Cidofivir - MOA
Cytosine Anolog
Does not require viral activation